2018 NHFA/CSANZ临床指南:心力衰竭的诊断和管理

2018-08-02 澳大利亚国家心脏基金会 Med J Aust. 2018 Aug 2.

2018年,澳大利亚国家心脏基金会(NHFA)联合澳大利亚和新西兰心脏学会(CSANZ)共同发布了心力衰竭的诊断和管理指南。心力衰竭是一组继发于心脏结构和功能异常的临床综合征,该指南主要聚焦心衰患者的诊断和管理,主要建议内容涉及血压和血脂水平的管理,钠糖共转运体抑制剂(SGLT-2)的应用降低2型糖尿病和心血管疾病患者心衰风险,疑似或新诊断心衰的检查,血管紧张素转换酶抑制剂,β受体阻滞剂以及盐皮质

中文标题:

2018 NHFA/CSANZ临床指南:心力衰竭的诊断和管理

英文标题:

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018.

发布日期:

2018-08-02

简要介绍:

2018年,澳大利亚国家心脏基金会(NHFA)联合澳大利亚和新西兰心脏学会(CSANZ)共同发布了心力衰竭的诊断和管理指南。心力衰竭是一组继发于心脏结构和功能异常的临床综合征,该指南主要聚焦心衰患者的诊断和管理,主要建议内容涉及血压和血脂水平的管理,钠糖共转运体抑制剂(SGLT-2)的应用降低2型糖尿病和心血管疾病患者心衰风险,疑似或新诊断心衰的检查,血管紧张素转换酶抑制剂,β受体阻滞剂以及盐皮质激素受体阻断剂的应用等。 

拓展指南:心力衰竭相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 NHFA/CSANZ临床指南:心力衰竭的诊断和管理)] GetToolGuiderByIdResponse(projectId=1, id=3b40a1c00162a1e8, title=2018 NHFA/CSANZ临床指南:心力衰竭的诊断和管理, enTitle=National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018., guiderFrom=Med J Aust. 2018 Aug 2., authorId=null, author=, summary=2018年,澳大利亚国家心脏基金会(NHFA)联合澳大利亚和新西兰心脏学会(CSANZ)共同发布了心力衰竭的诊断和管理指南。心力衰竭是一组继发于心脏结构和功能异常的临床综合征,该指南主要聚焦心衰患者的诊断和管理,主要建议内容涉及血压和血脂水平的管理,钠糖共转运体抑制剂(SGLT-2)的应用降低2型糖尿病和心血管疾病患者心衰风险,疑似或新诊断心衰的检查,血管紧张素转换酶抑制剂,β受体阻滞剂以及盐皮质, cover=, journalId=null, articlesId=null, associationId=412, associationName=澳大利亚国家心脏基金会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Aug 02 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年,澳大利亚国家心脏基金会(NHFA)联合澳大利亚和新西兰心脏学会(CSANZ)共同发布了心力衰竭的诊断和管理指南。心力衰竭是一组继发于心脏结构和功能异常的临床综合征,该指南主要聚焦心衰患者的诊断和管理,主要建议内容涉及血压和血脂水平的管理,钠糖共转运体抑制剂(SGLT-2)的应用降低2型糖尿病和心血管疾病患者心衰风险,疑似或新诊断心衰的检查,血管紧张素转换酶抑制剂,β受体阻滞剂以及盐皮质激素受体阻断剂的应用等。 </div> <div><br> </div> 拓展指南:<strong>与<font color=red>心力衰竭</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=734ae1c0015990e8" title="2018 ESC立场声明:晚期心力衰竭" target=_blank>2018 ESC立场声明:晚期心力衰竭</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=335431c001583eb6" title="心力衰竭容量管理中国专家建议" target=_blank>心力衰竭容量管理中国专家建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c71641c0015568c0" title="聚焦C期心力衰竭及其合并症的管理—2017 ACC/AHA/HFSA 心力衰竭管理指南更新解读" target=_blank>聚焦C期心力衰竭及其合并症的管理—2017 ACC/AHA/HFSA 心力衰竭管理指南更新解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=750351c001556ebc" title="慢性心力衰竭患者的心率管理策略" target=_blank>慢性心力衰竭患者的心率管理策略</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=346b51c00152e883" title="中国急性心力衰竭急诊临床实践指南(2017)" target=_blank>中国急性心力衰竭急诊临床实践指南(2017)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD" target=_blank>有关心力衰竭更多指南</a></ul>, tagList=[TagDto(tagId=335, tagName=心力衰竭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7036, appHits=536, showAppHits=0, pcHits=5083, showPcHits=1973, likes=140, shares=12, comments=3, approvalStatus=1, publishedTime=Mon Aug 06 21:11:22 CST 2018, publishedTimeString=2018-08-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Aug 06 21:11:22 CST 2018, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 23:01:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 NHFA/CSANZ临床指南:心力衰竭的诊断和管理)])
2018 NHFA/CSANZ临床指南:心力衰竭的诊断和管理
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=998381, encodeId=8ef099838174, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Sun Jul 11 10:05:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337704, encodeId=e9e933e70486, content=文章太简短了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Fri Aug 10 13:02:51 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336917, encodeId=aea433691e6f, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 06 23:16:36 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
    2021-07-11 湘雅科教

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=998381, encodeId=8ef099838174, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Sun Jul 11 10:05:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337704, encodeId=e9e933e70486, content=文章太简短了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Fri Aug 10 13:02:51 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336917, encodeId=aea433691e6f, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 06 23:16:36 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
    2018-08-10 1237db7em74暂无昵称

    文章太简短了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=998381, encodeId=8ef099838174, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Sun Jul 11 10:05:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337704, encodeId=e9e933e70486, content=文章太简短了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Fri Aug 10 13:02:51 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336917, encodeId=aea433691e6f, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 06 23:16:36 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
    2018-08-06 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦

    0